Skip to main content
Fig. 8 | Biomarker Research

Fig. 8

From: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation

Fig. 8

Clinical significance of SLC25A21-AS1. a The tumor tissues and adjacent normal tissues of 24 EOC patients were randomly selected, and the relative expressions of SLC25A21-AS1 in different groups were detected by real-time quantitative PCR. b Correlation analysis of SLC25A21-AS1 and PTBP3.The data were based on 19 patients with a decline in SLC25A21-AS1 in a. c Clinical survival analysis on SLC25A21-AS1 and PTBP3. The significance of the relationship was tested by the log-rank test. d Differences in relative expression levels of SLC25A21-AS1 and PTBP3 in patients with endometrial carcinoma (UCEC). The Wilcoxon rank sum test in R was used to statistically test the expression levels of target genes in target cancer samples, and set paired = TRUE. *P<0.05

Back to article page